Overview

P.Acnes Colony Count Following Subdermal Cefazolin

Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The specific outcome is to determine whether the colony count of Propionibacterium acnes, one of the commonest causes of shoulder infection and not eradicated by conventional forms of surgical preparatory solutions and antibiotics, in a shoulder surgical wound will be altered by the use of subdermal cefazolin.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of British Columbia
Treatments:
Cefazolin